
AOD9604 5mg
In Bali · Same-Day Delivery · CoA-Verified
Growth hormone fragment for targeted fat reduction — stimulates lipolysis and inhibits lipogenesis without affecting blood sugar or growth.
Low Stock — Selling Quickly
SKU: ML-AOD9604-5MG
💰 Volume Discounts:
Buy 3+ vials = 10% off · Buy 5+ vials = 15% off
AOD9604 is a modified fragment of human growth hormone (amino acids 176-191) specifically engineered to retain the fat-metabolising properties of HGH without its growth-promoting or diabetogenic effects. Originally developed by Monash University, AOD9604 reached Phase IIa clinical trials for obesity treatment. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) through beta-3 adrenergic receptor upregulation in adipose tissue — making it one of the most targeted fat-loss peptides available.
Local to Bali
Buying AOD9604 5mg in Bali
We hand-deliver AOD9604 5mg across Bali. Same-day for orders placed before 3pm local time. Order via the cart or WhatsApp — your choice. Every batch ships with a third-party Certificate of Analysis so you know exactly what you're buying.
Same-Day Delivery Zones
- Canggu
- Seminyak
- Ubud
- Uluwatu
- Sanur
- Denpasar
- Jimbaran
- Nusa Dua
Plus next-day nationwide delivery across Indonesia (Jakarta, Surabaya, Medan, Bandung, Makassar and more).
Why Buy AOD9604 5mg From Mito Labs
- Independent third-party CoA on every batch — purity verified before sale.
- Cold-chain handling for peptides that require it. No degraded product.
- IDR pricing with USD reference. Pay in Rupiah, no FX surprises.
- Bali-based team — WhatsApp support in English & Bahasa Indonesia.
Read the full AOD9604 5mg in Bali guide → delivery zones, pricing in IDR, and FAQs.
Related Products
FeaturedRetatrutide (RT3-GLP) 10mg
Triple receptor agonist studied in clinical research on GLP-1, GIP, and glucagon pathway modulation.

Retatrutide (RT3-GLP) 20mg
Triple receptor agonist (GLP-1/GIP/glucagon) — 20mg vial offers a lower cost per mg than the 10mg vial.

MOTS-C 40mg
Mitochondrial exercise mimetic — AMPK activation, insulin sensitivity, and fat metabolism. Larger dose vial for extended protocols.
FeaturedTirzepatide 10mg
Dual GLP-1/GIP receptor agonist — up to 22.5% body weight reduction in trials, the most effective approved weight loss compound to date.